Azioni Alexion Pharmaceuticals, Inc.
Azioni
ALXN
US0153511094
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01/08/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,61% | 660 Mrd | |
+24,18% | 562 Mrd | |
-5,24% | 358 Mrd | |
+16,49% | 322 Mrd | |
+8,28% | 297 Mrd | |
+12,40% | 219 Mrd | |
-9,94% | 196 Mrd | |
+6,81% | 199 Mrd | |
-8,75% | 149 Mrd |